Sep 8, 2026 07:01AM
Sep 1, 2026 07:02AM
Sep 1, 2026 07:01AM
Aug 18, 2026 06:42AM
Aug 13, 2026 04:05PM
Aug 4, 2026 07:01AM
Jul 8, 2026 06:43AM H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
Jul 6, 2026 07:06AM
Jul 6, 2026 07:01AM
Jul 2, 2026 07:01AM
Jun 29, 2026 07:00AM
Jun 16, 2026 07:01AM
Jun 16, 2026 07:01AM
Jun 9, 2026 07:01AM Invivyd begins Phase 3 trial comparing COVID antibody to mRNA vaccine
Jun 9, 2026 07:01AM
Jun 3, 2026 07:01AM
Jun 1, 2026 07:02AM
Jun 1, 2026 07:01AM
May 27, 2026 07:01AM
May 14, 2026 07:01AM
May 11, 2026 07:01AM Invivyd publishes research comparing COVID antibody to vaccine side effects
May 11, 2026 07:01AM
May 7, 2026 07:01AM
May 5, 2026 07:01AM
Apr 20, 2026 07:01AM
Apr 9, 2026 07:03AM
Apr 9, 2026 07:01AM
Apr 6, 2026 07:01AM Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 30, 2026 04:05PM
Mar 5, 2026 07:03AM
Mar 5, 2026 07:01AM
Mar 5, 2026 07:01AM
Mar 2, 2026 04:10PM
Mar 2, 2026 04:01PM
Feb 24, 2026 07:01AM New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
Feb 4, 2026 07:09AM
Feb 3, 2026 07:01AM
Feb 3, 2026 07:01AM
Jan 22, 2026 07:01AM
Jan 22, 2026 07:01AM
Jan 20, 2026 07:01AM
Jan 20, 2026 07:01AM Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026
Jan 8, 2026 07:08AM
Jan 8, 2026 07:01AM
Dec 23, 2025 07:05AM
Dec 23, 2025 07:05AM
Dec 23, 2025 07:01AM
Dec 23, 2025 07:01AM
Nov 25, 2025 07:01AM Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
Nov 24, 2025 07:01AM

330,680 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All